Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Sinopharm Tech Holdings's
Operating Income
for the
six
months ended in Dec. 2025 was HK$-1.55 Mil. Sinopharm Tech Holdings's Interest Expense for the
six
months ended in Dec. 2025 was HK$-2.14 Mil.
did not have earnings to cover the interest expense.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Sinopharm Tech Holdings's Interest Coverage or its related term are showing as below:
HKSE:08156's Interest Coverage is not ranked *
in the Software industry.
Industry Median: 26.755 * Ranked among companies with meaningful Interest Coverage only.
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Sinopharm Tech Holdings Interest Coverage Related Terms
Sinopharm Tech Holdings Interest Coverage Historical Data
* Premium members only.
The historical data trend for Sinopharm Tech Holdings's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
HKSE:08156 vs QH, SHOP, UBER: Interest Coverage Comparison
For the Software - Application subindustry, Sinopharm Tech Holdings's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sinopharm Tech Holdings Interest Coverage vs Software Industry
For the Software industry and Technology sector, Sinopharm Tech Holdings's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Sinopharm Tech Holdings's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Sinopharm Tech Holdings did not have earnings to cover the interest expense.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Interest Coverage of 0 (At Loss) mean?
Sinopharm Tech Holdings (HKSE:08156) has a Interest Coverage of 0 (At Loss) as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Sinopharm Tech Holdings and its competitors. According to the industry distribution chart, Sinopharm Tech Holdings ranks #999999 out of 1728 companies in the Software industry.
Is Sinopharm Tech Holdings' Interest Coverage too high?
Sinopharm Tech Holdings' current Interest Coverage is 0 (At Loss). Based on the distribution chart, Sinopharm Tech Holdings ranks #999999 out of 1728 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, Sinopharm Tech Holdings has a GF Score™ of 27/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sinopharm Tech Holdings' Interest Coverage compare to QH and SHOP?
According to the Software industry distribution chart, Sinopharm Tech Holdings ranks #999999 out of 1728 companies for Interest Coverage. This places Sinopharm Tech Holdings in the lower half of its industry. The industry median Interest Coverage is 26.76. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Software company?
The median Interest Coverage among Software companies is 26.76, based on 1,728 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Sinopharm Tech Holdings and its competitors. For the Software industry, the median Interest Coverage is 26.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sinopharm Tech Holdings's current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sinopharm Tech Holdings stock overvalued right now?
Based on GuruFocus' analysis, Sinopharm Tech Holdings (HKSE:08156) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.06, compared to a current price of HK$0.16 — trading 160% above its estimated fair value. The current Interest Coverage is 0 (At Loss). Sinopharm Tech Holdings' overall GF Score™ is 27/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Sinopharm Tech Holdings (HKSE:08156), the current Interest Coverage is 0 (At Loss) as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sinopharm Tech Holdings (HKSE:08156) Overvalued in 2026?
Based on GuruFocus' analysis, Sinopharm Tech Holdings stock appears to be overvalued.
The current stock price of HK$0.16 is trading 160% above its estimated GF Value™ of HK$0.06.
GuruFocus considers Sinopharm Tech Holdings to be Significantly Overvalued.
Key valuation signals for HKSE:08156:
Interest Coverage: 0 (At Loss)
GF Value™: HK$0.06 vs. price of HK$0.16 (160% above fair value)
No single metric tells the full story. See the HKSE:08156 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sinopharm Tech Holdings Ltd is an investment holding company operating through three segments: Internet Plus services, Supply Chain services, and Manufacturing and distribution of personal protective equipment. The company generates the majority of its revenue from the Supply Chain services segment, which includes supply chain management, data analysis, and trading of medical and related products. Geographically, it operates in Hong Kong and the People's Republic of China (PRC), with the majority of its revenue coming from the PRC.
27GF Score
Get the complete analysis for HKSE:08156
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08156 has been successfully added to your 
